13 Most Oversold Healthcare Stocks So Far in 2025

Page 11 of 11

1. Soleno Therapeutics, Inc. (NASDAQ:SLNO)

Relative Strength Index (RSI): 25.03 

Soleno Therapeutics, Inc. (NASDAQ:SLNO) tops our list for being one of the most oversold stocks. It is a clinical-stage biotech focused on rare diseases and has seen significant stock volatility in 2025 following the commercial launch of its lead product, VYKAT XR, the first FDA-approved treatment for hyperphagia in Prader-Willi Syndrome (PWS). The therapy addresses extreme hunger and metabolic challenges in PWS patients and represents a key step in the company’s rare disease portfolio.

The stock experienced a sharp decline in mid-August after a short-seller report raised safety concerns about VYKAT XR, triggering a selloff of over 10% in two trading days and a subsequent securities class action investigation. Despite this, the drug has gained early traction, with 646 patient initiations from 295 prescribers covering more than 100 million U.S. lives. Soleno Therapeutics, Inc. (NASDAQ:SLNO) is also pursuing European approval through the EMA, signaling its strategy for international market expansion.

Market reaction has left the business among the most oversold healthcare stocks of 2025, with the stock losing roughly 26% in a month. However, technical indicators suggest the selling pressure may be nearing exhaustion. Analysts remain optimistic, maintaining buy ratings with average price targets of $110–$120, reflecting confidence in the firm’s long-term commercial potential.

Soleno Therapeutics, Inc. (NASDAQ:SLNO) continues to focus on raising awareness of VYKAT XR through clinical data presentations and targeted commercialization efforts, aiming to secure a solid foothold in the PWS treatment market despite short-term headwinds.

While we acknowledge the potential of SLNO to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than SLNO and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 11 of 11